In NSCLC cells with the EGFR mutation, the signal is always on ... for patients who have a mutation in the ALK, BRAF, ROS1, ...
The two drugs work together by blocking the growth signal coming from the mutant BRAF protein and can slow or even stop the ...
The main goal of our laboratory is the identification and characterization of signal transduction pathways that cause ... As we have reported, the BRAF and RAS mutant tumors are more sensitive to ERK ...